Bríd M Ryan

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. doi request reprint Survivin: a new target for anti-cancer therapy
    Bríd M Ryan
    Cancer Prevention Fellowship Program, Office of Preventive Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 4258, USA
    Cancer Treat Rev 35:553-62. 2009

Collaborators

Detail Information

Publications1

  1. doi request reprint Survivin: a new target for anti-cancer therapy
    Bríd M Ryan
    Cancer Prevention Fellowship Program, Office of Preventive Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 4258, USA
    Cancer Treat Rev 35:553-62. 2009
    ..The optimum use of survivin antagonists in the treatment of cancer is likely to be in combination with conventional cancer therapies...